New basal insulin Toujeo (insulin glargine U300) has now launched in the US, around a month after its FDA approval. In what we think is fantastic news, Toujeo will be priced around the same as Lantus (insulin glargine U100) per unit.
Read more
Toujeo Launches in the US – The Next Generation Lantus
Posted in Glucose & Insulin